CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $6,599,000 | +161.6% | 145,479 | +138.8% | 0.01% | +150.0% |
| Q2 2014 | $2,523,000 | +2.3% | 60,923 | +71.1% | 0.00% | 0.0% |
| Q1 2014 | $2,466,000 | -15.3% | 35,612 | -26.3% | 0.00% | -33.3% |
| Q4 2013 | $2,910,000 | +531.2% | 48,289 | +537.5% | 0.00% | – |
| Q3 2013 | $461,000 | +28.8% | 7,575 | +41.6% | 0.00% | – |
| Q2 2013 | $358,000 | – | 5,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |